arrow
Y

Yiannis Kallis

Queen Mary University of London
H指数:17
被引数:1,859

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Seladelpar improves liver stiffness in PBC: ASSURE interim analysis

Seladelpar改善原发性胆汁性胆管炎患者的肝硬度:ASSURE中期分析

2026-10-060
OA
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial

Levy, C.; Abouda, G.F.; Bilir, B.M.; Bonder, A.; Bowlus, C.L.; Campos-Varela, I.; Cazzagon, N.; Chandok, N.; Cheent, K.; Cortez-Pinto, H.; 等. Elafibranor在原发性硬化性胆管炎中的安全性与有效性:ELMWOOD II期随机对照试验. J. Hepatol. 2025. [Google Scholar] [CrossRef] [PubMed]

2025-05-100
OAAI
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Seladelpar在原发性胆汁性胆管炎中的3期试验

2024-02-2932
PRE
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

英国范围内对原发性胆汁性胆管炎二线治疗的多中心评估

2023-06-0117
OA